Jane Street’s Edgewise Therapeutics EWTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $658K | Buy |
50,185
+35,427
| +240% | +$464K | ﹤0.01% | 3394 |
|
2025
Q1 | $325K | Sell |
14,758
-15,800
| -52% | -$348K | ﹤0.01% | 4475 |
|
2024
Q4 | $816K | Sell |
30,558
-19,812
| -39% | -$529K | ﹤0.01% | 3232 |
|
2024
Q3 | $1.34M | Sell |
50,370
-14,117
| -22% | -$377K | ﹤0.01% | 2969 |
|
2024
Q2 | $1.16M | Buy |
64,487
+37,341
| +138% | +$673K | ﹤0.01% | 3471 |
|
2024
Q1 | $495K | Sell |
27,146
-16,993
| -38% | -$310K | ﹤0.01% | 4058 |
|
2023
Q4 | $483K | Buy |
+44,139
| New | +$483K | ﹤0.01% | 4147 |
|
2023
Q3 | – | Sell |
-15,438
| Closed | -$120K | – | 5293 |
|
2023
Q2 | $120K | Sell |
15,438
-16,215
| -51% | -$126K | ﹤0.01% | 4751 |
|
2023
Q1 | $211K | Sell |
31,653
-224
| -0.7% | -$1.49K | ﹤0.01% | 4634 |
|
2022
Q4 | $285K | Buy |
31,877
+13,288
| +71% | +$119K | ﹤0.01% | 4016 |
|
2022
Q3 | $183K | Buy |
18,589
+7,084
| +62% | +$69.7K | ﹤0.01% | 4632 |
|
2022
Q2 | $92K | Buy |
+11,505
| New | +$92K | ﹤0.01% | 4768 |
|